Aptos articles
-
Could DTX Exchange (DTX) Overtake Shiba Inu (SHIB) And Aptos (APT)? Early Investors Are Optimistic
DTX Exchange's presale heats up while SHIB and APT face challenges. Analysts predict massive growth, could it overtake these popular cryptos?
-
Aptose Biosciences (NASDAQ:APTO) Price Target Cut to $6.00 by Analysts at Canaccord Genuity Group
Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) had its price target reduced by Canaccord Genuity Group from $15.00 to $6.00 in a research note released on Thursday, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on APTO. HC Wainwright restated […]